Nbt Bank N A Boosted Gilead Sciences (GILD) Position By $346,194; Jagged Peak Energy (JAG) Shorts Lowered By 6.46%

January 15, 2018 - By Hazel Jackson

Jagged Peak Energy Incorporated (NYSE:JAG) had a decrease of 6.46% in short interest. JAG’s SI was 5.78M shares in January as released by FINRA. Its down 6.46% from 6.18 million shares previously. With 750,200 avg volume, 8 days are for Jagged Peak Energy Incorporated (NYSE:JAG)’s short sellers to cover JAG’s short positions. The SI to Jagged Peak Energy Incorporated’s float is 14.34%. The stock decreased 2.58% or $0.39 during the last trading session, reaching $14.73. About 1.50 million shares traded or 67.41% up from the average. Jagged Peak Energy Inc. (NYSE:JAG) has 0.00% since January 15, 2017 and is . It has underperformed by 16.70% the S&P500.

Nbt Bank N A increased Gilead Sciences Inc (GILD) stake by 12.25% reported in 2017Q3 SEC filing. Nbt Bank N A acquired 4,274 shares as Gilead Sciences Inc (GILD)’s stock declined 8.05%. The Nbt Bank N A holds 39,166 shares with $3.17M value, up from 34,892 last quarter. Gilead Sciences Inc now has $103.22 billion valuation. The stock decreased 0.05% or $0.04 during the last trading session, reaching $79.02. About 6.37M shares traded. Gilead Sciences, Inc. (NASDAQ:GILD) has declined 21.80% since January 15, 2017 and is downtrending. It has underperformed by 38.50% the S&P500.

Among 11 analysts covering Jagged Peak Energy (NYSE:JAG), 10 have Buy rating, 0 Sell and 1 Hold. Therefore 91% are positive. Jagged Peak Energy had 12 analyst reports since February 21, 2017 according to SRatingsIntel. The stock of Jagged Peak Energy Inc. (NYSE:JAG) has “Outperform” rating given on Tuesday, February 21 by Credit Suisse. The firm has “Overweight” rating by JP Morgan given on Tuesday, February 21. The stock of Jagged Peak Energy Inc. (NYSE:JAG) earned “Hold” rating by BMO Capital Markets on Thursday, March 23. Stifel Nicolaus initiated the stock with “Buy” rating in Thursday, March 16 report. On Tuesday, February 21 the stock rating was initiated by Wells Fargo with “Outperform”. KLR Group initiated the shares of JAG in report on Monday, June 19 with “Buy” rating. RBC Capital Markets initiated it with “Outperform” rating and $20 target in Tuesday, February 21 report. Goldman Sachs initiated the shares of JAG in report on Tuesday, February 21 with “Buy” rating. The rating was initiated by UBS on Thursday, March 23 with “Buy”. As per Tuesday, October 17, the company rating was initiated by Bank of America.

Jagged Peak Energy Inc., an independent oil and natural gas company, focuses on the acquisition and development of unconventional oil and associated liquids-rich natural gas reserves in the Southern Delaware basin, a sub-basin of the Permian basin of West Texas. The company has market cap of $3.14 billion. As of December 31, 2016, it held a 92% average working interest in approximately 66,393 net acres; and had 37,695 thousand barrel of oil equivalent of estimated net proved reserves, as well as owned a 98% average working interest in 49 net productive wells. It currently has negative earnings.

Investors sentiment increased to 1.03 in Q3 2017. Its up 0.10, from 0.93 in 2017Q2. It is positive, as 96 investors sold GILD shares while 488 reduced holdings. 127 funds opened positions while 474 raised stakes. 957.62 million shares or 2.06% more from 938.32 million shares in 2017Q2 were reported. Puzo Michael J reported 15,846 shares. Allsquare Wealth Ltd Limited Liability Company has 0.08% invested in Gilead Sciences, Inc. (NASDAQ:GILD). Glovista Invests Limited Liability reported 7,535 shares. Guggenheim Capital Limited Liability Corp invested in 0.28% or 1.50 million shares. Orleans Cap Mgmt Corp La has 17,017 shares. Moreover, Middleton Incorporated Ma has 1.51% invested in Gilead Sciences, Inc. (NASDAQ:GILD) for 103,408 shares. Omers Administration Corporation has 37,800 shares for 0.03% of their portfolio. Bluemountain Capital Limited Liability Company invested in 0.22% or 133,563 shares. Robeco Institutional Asset Management Bv holds 467,886 shares or 0.23% of its portfolio. Eagle Advisors Ltd Liability Co holds 0.15% in Gilead Sciences, Inc. (NASDAQ:GILD) or 62,485 shares. Smith Salley & Associate invested in 52,105 shares. Brandes Invest Prns LP reported 70,262 shares or 0.14% of all its holdings. Northeast Management has invested 0.05% in Gilead Sciences, Inc. (NASDAQ:GILD). Northwest Counselors Ltd Limited Liability Company reported 0.03% in Gilead Sciences, Inc. (NASDAQ:GILD). Reliance Communication Of Delaware invested 0.08% of its portfolio in Gilead Sciences, Inc. (NASDAQ:GILD).

Nbt Bank N A decreased Lowes Cos Inc (NYSE:LOW) stake by 6,885 shares to 113,620 valued at $9.08 million in 2017Q3. It also reduced Prudential Finl Inc (NYSE:PRU) stake by 4,113 shares and now owns 32,481 shares. Chevron Corporation (NYSE:CVX) was reduced too.

Since August 1, 2017, it had 0 insider purchases, and 11 sales for $41.13 million activity. Alton Gregg H had sold 15,000 shares worth $1.11M on Tuesday, January 2. On Thursday, August 31 Meyers James R sold $4.99M worth of Gilead Sciences, Inc. (NASDAQ:GILD) or 60,000 shares. On Tuesday, August 1 the insider MARTIN JOHN C sold $5.56 million. Another trade for 51,820 shares valued at $4.40M was made by Washington Robin L on Thursday, September 7.

Among 30 analysts covering Gilead Sciences (NASDAQ:GILD), 18 have Buy rating, 0 Sell and 12 Hold. Therefore 60% are positive. Gilead Sciences had 111 analyst reports since July 29, 2015 according to SRatingsIntel. The stock has “Equal-Weight” rating by Morgan Stanley on Friday, October 6. Needham maintained Gilead Sciences, Inc. (NASDAQ:GILD) on Tuesday, October 3 with “Hold” rating. The stock of Gilead Sciences, Inc. (NASDAQ:GILD) earned “Hold” rating by Maxim Group on Friday, April 29. The rating was upgraded by Jefferies on Tuesday, September 6 to “Buy”. The rating was upgraded by Jyske Bank on Thursday, September 10 to “Strong Buy”. The firm has “Hold” rating by Maxim Group given on Tuesday, May 30. The stock of Gilead Sciences, Inc. (NASDAQ:GILD) has “Outperform” rating given on Wednesday, July 29 by RBC Capital Markets. The firm earned “Buy” rating on Monday, October 16 by Robert W. Baird. The stock of Gilead Sciences, Inc. (NASDAQ:GILD) earned “Hold” rating by Jefferies on Wednesday, October 4. Oppenheimer maintained Gilead Sciences, Inc. (NASDAQ:GILD) on Tuesday, October 20 with “Outperform” rating.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: